Ghorbani Marjan, Hamishehkar Hamed
Institute for Stem Cell and Regenerative, Tabriz University of Medical Sciences, Tabriz, Iran.
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mater Sci Eng C Mater Biol Appl. 2017 Dec 1;81:561-570. doi: 10.1016/j.msec.2017.08.021. Epub 2017 Aug 3.
The aim of this study was to design and develop a new pH-responsive nano-platform for controlled and targeted delivery of anticancer drugs. Engineering of pH-responsive nanocarriers was prepared via decoration of gold nanoparticles (NPs) by thiolated (methoxy-poly(ethylene glycol)-b-poly((2-dimethylamino) ethyl methacrylate-co-itaconic acid) (mPEG-b-p(DMAEMA-co-IA) copolymer and fully characterized by various techniques and subsequently used for loading and targeted delivery of anticancer agent, methotrexate (MTX). By conjugation of MTX with the amino groups of polymeric shell of gold NPs (with the high loading capacity of 31%), since MTX is also the target ligand of folate receptors, the targeted performance of NPs examined through the cell uptake study. The results indicated that MTX-loaded NPs showed 1.3 times more cell internalization than MTX free NPs. Cell cytotoxicity studies pointed out ~1.5 and 3 times higher cell cytotoxicity after 24h for MTX-loaded nanoparticles than MTX in MTT assay and cell cycle arrest experiments, respectively. Additionally, mPEG was used as the outer shell of NPs which caused the long-term dispersibility of the NPs even under high ionic strength. The in-vitro pH-triggered drug release of MTX showed that MTX released more than three times in simulated cancerous tissue (40°C, pH5.3) than physiologic condition (37°C, pH7.4) during 48h. The results of various experiments determined that the developed smart nanocarrier proposed as a promising nanocarrier for active and passive targeting of anionic anti-cancer agents such as MTX.
本研究的目的是设计并开发一种新型的pH响应性纳米平台,用于抗癌药物的可控靶向递送。通过用硫醇化的(甲氧基聚(乙二醇)-b-聚((2-二甲基氨基)乙基甲基丙烯酸酯-共-衣康酸)(mPEG-b-p(DMAEMA-co-IA))共聚物修饰金纳米颗粒(NPs)来制备pH响应性纳米载体,并通过各种技术对其进行全面表征,随后用于负载和靶向递送抗癌剂甲氨蝶呤(MTX)。由于MTX也是叶酸受体的靶配体,通过将MTX与金纳米颗粒聚合物壳的氨基结合(负载量高达31%),通过细胞摄取研究来检测纳米颗粒的靶向性能。结果表明,负载MTX的纳米颗粒的细胞内化量比未负载MTX的纳米颗粒高1.3倍。细胞毒性研究指出,在MTT试验和细胞周期阻滞实验中,负载MTX的纳米颗粒在24小时后的细胞毒性分别比MTX高约1.5倍和3倍。此外,mPEG被用作纳米颗粒的外壳,这使得纳米颗粒即使在高离子强度下也能长期分散。MTX的体外pH触发药物释放表明,在48小时内,MTX在模拟癌组织(40°C,pH5.3)中的释放量比生理条件(37°C,pH7.4)下多三倍以上。各种实验结果表明,所开发的智能纳米载体有望成为一种用于主动和被动靶向阴离子抗癌剂(如MTX)的纳米载体。